Antiva Biosciences
PrivateLast Round
Series E
Apr 27, 2023
Total Funding Raised
$141.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Antiva Biosciences is a biotechnology company that develops small molecule antivirals aimed at enhancing health outcomes for patients affected by HPV and other viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antiva Biosciences Comparables
Compare Antiva Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frantz Viral Therapeutics | 82% | |
| Amplexd Therapeutics | 76% | |
| Asieris Pharmaceuticals | 73% | |
Antiva Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 27, 2023 | ||||
| Series D | Nov 2, 2021 | ||||
| Series C Extension | Jul 10, 2018 | ||||
| Series C | Mar 28, 2017 | ||||
| Series B | Aug 6, 2015 | ||||
Series A | Jul 1, 2014 |
Antiva Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series C Extension, Series D |
| Brace Pharma Capital | Series C, Series C Extension, Series D |
| GV | Series E, Series D |
| Hillhouse Investment | Series C Extension |
| Gaingels | Series D |
| Mana Ventures | Series D |
| Avestria Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 70% MoM.
- May 15, 2026
Monthly visitors grew 530% MoM, reaching 1.8K.
Antiva Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antiva Biosciences's valuation, stock price, and market status.